RNAIL1R2+TregHNSCC

Haiyan Guo1, Chun Liu2, Kun Wu3

  • 1Department of Clinical Immunology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, 639 Zhizaoju Road, Shanghai, 200011, China.

概括

研究人员确定了一种特定的调控性T细胞 (Treg) 子集,IL1R2+Treg,它促进了头部和部状细胞癌 (HNSCC) 的进展. 向IL1R2和CTLA4可能提供一个有效的HNSCC治疗策略.